Evidence map›Paper›PMID 28103952›Full record

ArticleMicrobiome2017

The interaction between vaginal microbiota, cervical length, and vaginal progesterone treatment for preterm birth risk.

Lindsay M Kindinger, Phillip R Bennett, Yun S Lee, Julian R Marchesi, Ann Smith, Stefano Cacciatore, Elaine Holmes, Jeremy K Nicholson, T G Teoh, David A MacIntyre

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in Microbiome, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 218 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
218citing papers in PubMed, 5 pooled it
23.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03992534 phase1unknown statusnot on this mapstarted 2019, after this paper: background citation

Feasibility, Safety, Tolerance and Assessment of LACTIN-V Use in a Cohort of Pregnant Women at Risk of Preterm Birth

TypeinterventionalSponsorImperial College LondonRan2019 to 2021Enrolled60ConditionsPreterm Labor, Preterm Birth, Preterm Premature Rupture of Membrane, Cervical IncompetenceArmsLACTIN-V
NCT04165252 unknown statusnot on this mapstarted 2020, after this paper: background citation

Evaluation of the Relationship Between Vaginal, Placental and Neonatal Mycobiota and Microbiome With Preterm Birth in Women With Short Cervical Length

Typeobservational_patient_registrySponsorKoç UniversityRan2020 to 2022Enrolled92ConditionsPreterm Birth, Microbial ColonizationArmsCollection of vaginal, neonatal buccal and placental samples
3 · Its place in the literature

Who cites it

218 citing papers in PubMed, 5 syntheses or guidelines pooled it, 379 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Contribution ofFrontiers in cellular and infection microbiology · 2021
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Vaginal microbiota stability over 18 months in young student women in France.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2024
    Trial
  8. Pharmacokinetics of vaginal progesterone in pregnancy.American journal of obstetrics and gynecology · 2019
    Trial
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Induction of Human β-Defensin-2 by VaginalOpen forum infectious diseases · 2026
    Article

158 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Lindsay M KindingerImperial College Parturition Research Group, Division of the Institute of Reproductive and Developmental Biology, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Hammersmith Campus, London, W12 0NN, UK.
Phillip R BennettImperial College Parturition Research Group, Division of the Institute of Reproductive and Developmental Biology, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Hammersmith Campus, London, W12 0NN, UK.
Yun S LeeImperial College Parturition Research Group, Division of the Institute of Reproductive and Developmental Biology, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Hammersmith Campus, London, W12 0NN, UK.
Julian R MarchesiCentre for Digestive and Gut Health, Department of Surgery and Cancer and the Institute of Global Health Innovation, Faculty of Medicine, Imperial College London, London, UK.
Ann SmithSchool of Biosciences, Cardiff University, Cardiff, UK.
Stefano CacciatoreImperial College Parturition Research Group, Division of the Institute of Reproductive and Developmental Biology, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Hammersmith Campus, London, W12 0NN, UK.
Elaine HolmesCentre for Digestive and Gut Health, Department of Surgery and Cancer and the Institute of Global Health Innovation, Faculty of Medicine, Imperial College London, London, UK.
Jeremy K NicholsonCentre for Digestive and Gut Health, Department of Surgery and Cancer and the Institute of Global Health Innovation, Faculty of Medicine, Imperial College London, London, UK.
T G TeohImperial College Parturition Research Group, Division of the Institute of Reproductive and Developmental Biology, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Hammersmith Campus, London, W12 0NN, UK.
David A MacIntyreImperial College Parturition Research Group, Division of the Institute of Reproductive and Developmental Biology, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Hammersmith Campus, London, W12 0NN, UK. d.macintyre@imperial.ac.uk.
Imperial College London · GBCardiff University · GBImperial College Healthcare NHS Trust · GBSt Mary's Hospital · GB

Funding

Medical Research Council MR/L009226/1
6 · The paper itself

Abstract

backgroundPreterm birth is the primary cause of infant death worldwide. A short cervix in the second trimester of pregnancy is a risk factor for preterm birth. In specific patient cohorts, vaginal progesterone reduces this risk. Using 16S rRNA gene sequencing, we undertook a prospective study in women at risk of preterm birth (n = 161) to assess (1) the relationship between vaginal microbiota and cervical length in the second trimester and preterm birth risk and (2) the impact of vaginal progesterone on vaginal bacterial communities in women with a short cervix.

resultsLactobacillus iners dominance at 16 weeks of gestation was significantly associated with both a short cervix <25 mm (n = 15, P < 0.05) and preterm birth <34

conclusionsL. iners dominance of the vaginal microbiota at 16 weeks of gestation is a risk factor for preterm birth, whereas L. crispatus dominance is protective against preterm birth. Vaginal progesterone does not appear to impact the pregnancy vaginal microbiota. Patients and clinicians who may be concerned about "infection risk" associated with the use of a vaginal pessary during high-risk pregnancy can be reassured.

Indexed as

Cervical Length MeasurementAdultBacterial LoadCervix UteriCross-Sectional StudiesDysbiosisFemaleHumansLactobacillusMicrobiotaPessariesPregnancyPregnancy, High-RiskPregnancy OutcomePremature BirthProgesteroneProgesteroneRNA, Ribosomal, 16SCervical lengthLactobacillusPreterm birthProgesteroneVaginal microbiome

Identifiers

PMID28103952
PMCPMC5244550
OpenAlexW2572899228

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.